Do children receiving HAART need to be revaccinated?
Bhattacharya, S.D.; Bhattacharyya, S.
LANCET. Infectious Diseases 11(6): 425
2011
ISSN/ISBN: 1474-4457 PMID: 21616453 DOI: 10.1016/s1473-3099(11)70129-3Document Number: 220066
Document emailed within 0-6 h
Related Documents
Rainwater-Lovett, K.; Moss, W.J. 2011: Immunologic basis for revaccination of HIV-infected children receiving HAART Future Virology 6(1): 59-71Wen, Y.; Shi, Y.; Jiang, C.; Detels, R.; Wu, D. 2013: HIV/AIDS patients' medical and psychosocial needs in the era of HAART: a cross-sectional study among HIV/AIDS patients receiving HAART in Yunnan, China Aids Care 25(7): 915-925
Chandrasekhar, A.; Gupta, A. 2011: Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART? American Journal of Clinical Nutrition 94(6): 1703s-1715s
Belaunzarán-Zamudio, P.F.; García-León, M.L.; Wong-Chew, R.M.ía.; Villasís-Keever, A.; Cuellar-Rodríguez, J.; Mosqueda-Gómez, J.L.; Muñoz-Trejo, T.; Escobedo, K.; Santos, J.é I.; Ruiz-Palacios, G.M.; Sierra-Madero, J.G. 2009: Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART Vaccine 27(50): 7059-7064
Olagbuji, B.N.; Ezeanochie, M.C.; Ande, A.B.; Oboro, V.O. 2010: Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria Archives of Gynecology and Obstetrics 281(6): 991-994
Pomerantz, R.J. 1999: HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy American Family Physician 59(10): 2855
Burda, S.T.; Viswanath, R.; Zhao, J.; Kinge, T.; Anyangwe, C.; Tinyami, E.T.; Haldar, B.; Powell, R.L.R.; Jarido, V.; Hewlett, I.K.; Nyambi, P.N. 2010: HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon Journal of Medical Virology 82(2): 187-196
Da Silva, C.A.L.; Dourado, I.ês.; Dahia, S.R.; Harzheim, E.; Rutherford, G.W. 2008: Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil Journal of Public Health Dentistry 68(3): 178-181
Krzyszkowska, A.; Leowski, J.; Górski, S.; Iwanowa, O.; Lenkiewicz, B.; Michalowicz, Z.; Szumilak, I.; Wasowska, J. 1977: Tuberculin allergy in children vaccinated with BCG for the 1st time and in revaccinated children. II. Tuberculin allergy in school children Pneumonologia Polska 45(5): 369-376
Karmakar, S.; Sharma, S.K.; Vashishtha, R.; Sharma, A.; Ranjan, S.; Gupta, D.; Sreenivas, V.; Sinha, S.; Biswas, A.; Gulati, V. 2011: Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART Clinical and Developmental Immunology 2011: 239021
Lertcheewakarn, P.; Tongprasert, F. 2014: A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 97(4): 361-368
Djarma, O.ïm.; Nguyen, Y.; Renois, F.; Djimassal, A.; Banisadr, F.; Andreoletti, L. 2014: Continuous free access to HAART could be one of the potential factors impacting on loss to follow-up in HAART-eligible patients living in a resource-limited setting: N'djamena, Chad Transactions of the Royal Society of Tropical Medicine and Hygiene 108(11): 735-738
Pensi, T.; Hemal, A.; Banerjee, T. 2012: Simultaneous HAART improves survival in children coinfected with HIV and TB Tropical Medicine and International Health: Tm and Ih 17(1): 52-58
Nyesigire Ruhinda, E.; Bajunirwe, F.; Kiwanuka, J. 2012: Anaemia in HIV-infected children: severity, types and effect on response to HAART Bmc Pediatrics 12: 170
Shah, I.; Katira, B. 2009: Tuberculosis co-infection in HAART naive HIV infected children - an Indian study Indian Journal of Pediatrics 76(9): 966-967
Parakh, A.; Dubey, A.P.; Kumar, A.; Maheshwari, A.; Saxena, R. 2009: Efficacy of first-line, WHO recommended generic HAART regimens in Indian children Kathmandu University Medical Journal 7(27): 220-225
Kornetova, N.V. 1975: Clinical course of pulmonary tuberculosis in adolescents revaccinated with BCG by intradermal method Problemy Tuberkuleza 7: 26-30
Kumarasamy, N.; Venkatesh, K.K.; Devaleenol, B.; Poongulali, S.; Mothi, S.N.; Solomon, S. 2009: Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India Journal of Tropical Pediatrics 55(3): 155-159
Lapphra, K.; Vanprapar, N.; Phongsamart, W.; Chearskul, P.; Chokephaibulkit, K. 2005: Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 88(7): 956-966
Sophan, S.; Meng, C.Y.; Pean, P.; Harwell, J.; Hutton, E.; Trzmielina, S.; Somasundaran, M.; Luzuriaga, K.; Pugatch, D. 2010: Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART) Southeast Asian Journal of Tropical Medicine and Public Health 41(1): 126-137